Volume 23, Issue 5 , Pages 600-606, October 2009
Desflurane-Induced Cardioprotection Against Ischemia-Reperfusion Injury Depends On Timing
Objectives
The authors tested the hypothesis that desflurane-induced cardioprotection depends on the timing of application and whether desflurane-induced postconditioning is mediated by nitric oxide.
Design
A prospective randomized vehicle-controlled study.
Setting
A university research laboratory.
Subjects
New Zealand White rabbits (N = 56).
Interventions
Rabbits were instrumented and subjected to a 30-minute coronary artery occlusion (CAO) and 3 hours of reperfusion. Animals were randomized to 8 groups (n = 7) and received 0.0 or 1.0 minimum alveolar concentration desflurane for 30 minutes before CAO (PRE), during CAO (ISCH), after CAO (POST), before and after CAO (PRE + POST), or continuously for 90 minutes starting 30 minutes before CAO (PRE + ISCH + POST). In 2 separate experimental groups, the nitric oxide synthase inhibitor N-omega-nitro-L-arginine (L-NA) was administered before reperfusion in the presence or absence of desflurane. Data are mean ± standard deviation.
Results
Infarct size was 68% ± 14% in control experiments. Desflurane significantly (p < 0.05) reduced infarct size in the PRE (43% ± 9%) and POST groups (49% ± 12%) but not in the ISCH group (69% ± 9%). The PRE + ISCH + POST and PRE + POST groups produced similar reductions in infarct size to 47% ± 12% and 43% ± 9%, respectively. L-NA alone had no effect on infarct size (61% ± 9%) but blocked postconditioning completely (L-NA + POST, 68% ± 10%).
Conclusions
Desflurane induces pre- and postconditioning but does not confer cardioprotection during ischemia in rabbits. The combination of pre- and postconditioning or continuous application does not provide additional cardioprotection. Furthermore, desflurane-induced postconditioning is mediated by nitric oxide.
Key Words: cardioprotection, reperfusion injury, preconditioning, postconditioning, desflurane, volatile anesthetics, myocardial infarction, rabbit
To access this article, please choose from the options below
Supported in part by an unrestricted investigator initiated research grant of Baxter Healthcare, Heidelberg, Germany, and grant 01 KS 9603 from the Ministry for Education and Research of the Federal Republic of Germany, Interdisciplinary Centre for Clinical Research (IZKF), Würzburg, Germany.
PII: S1053-0770(08)00350-9
doi:10.1053/j.jvca.2008.11.004
© 2009 Elsevier Inc. All rights reserved.
Volume 23, Issue 5 , Pages 600-606, October 2009
